Insulin Glargine Solostar Injection, Solution
Product Images NDC 50090-6178

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Insulin Glargine Solostar (NDC 50090-6178). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Insulin 01)

Chemical structure diagram of insulin glargine composed of two peptide chains labeled A and B. The diagram illustrates the amino acid sequence in each chain with disulfide bonds indicated between specific cysteine residues, showing the protein's primary structure.*

FDA Label Image

Figure 1 (Insulin 02)

A line graph comparing glucose infusion rate (mg/kg/min) versus time in hours after subcutaneous injection for insulin glargine and NPH insulin. The graph shows different infusion rate profiles over a 30-hour period, with a marked end of observation period indicated on the time axis.*

FDA Label Image

Image (Insulin 03)

An illustration showing hands preparing an injection vial, with one hand holding the vial and the other hand removing or placing a rubber stopper. The image likely depicts handling of an injectable medication vial.*

FDA Label Image

Image (Insulin 04)

Black and white line drawing showing hands holding an insulin vial. One hand is peeling off a protective cap or seal from the vial, illustrating preparation for subcutaneous injection.*

FDA Label Image

Image (Insulin 05)

Illustrations showing hands preparing a syringe for use with Insulin Glargine Solostar injection. The left image shows a hand pressing down on the syringe plunger. The right image shows removing a protective needle cap before injection.*

FDA Label Image

Image (Insulin 06)

An instructional illustration showing a hand holding an injection pen device, with the other hand twisting or pulling a cap or protective cover from the needle area. The image likely demonstrates preparation steps for an injection.*

FDA Label Image

Image (Insulin 07)

An instructional diagram showing a hand holding a syringe with a needle inserted into a vial, and another hand with the index finger positioned near the syringe plunger, indicating the direction to push the plunger down to withdraw the injection solution.*

FDA Label Image

Image (Insulin 08)

An instructional illustration depicting hands preparing a subcutaneous injection. One hand is pulling back skin, while the other holds and positions the syringe needle for injection, demonstrating proper technique for administering a subcutaneous injection.*

FDA Label Image

Image (Insulin 09)

An instructional black and white line drawing showing a person's hands holding a syringe. One hand is stabilizing the syringe, while the other is adjusting the plunger or cap, indicated by an arrow pointing toward it. This image likely demonstrates how to prepare or use the syringe for injection.*

FDA Label Image

Image (Insulin 10)

An instructional diagram illustrating components of the Insulin Glargine Solostar injection pen. It labels the pen cap, pen needle system including protective seal, and the pen body featuring the insulin reservoir, rubber seal, dose window, dosage selector, and injection button.*

FDA Label Image

Image (Insulin 11)

An instructional illustration showing a hand holding an insulin pen and another hand removing or attaching the pen cap. The insulin pen is marked with dosage measurements and intended for subcutaneous injection.*

FDA Label Image

Image (Insulin 12)

An instructional illustration showing hands holding an insulin injection pen and removing a needle cap. The image appears to demonstrate part of the injection preparation process for insulin.*

FDA Label Image

Image (Insulin 13)

Illustration showing a close-up of a hand turning the dial of an Insulin Glargine Solostar pen injector to set the dose, with a red arrow indicating the direction of rotation. The visible dose window shows a partial number.*

FDA Label Image

Image (Insulin 14)

An instructional diagram showing components of an insulin injection pen. The image depicts a needle cap labeled 'Keep' and a syringe needle labeled 'Discard', with arrows indicating removal of the needle cap from the insulin pen prior to use.*

FDA Label Image

Image (Insulin 15)

An instructional diagram showing correct preparation of an insulin glargine injection using a prefilled SoloStar pen. It depicts uncovering the needle cap and holding the pen vertically with the needle pointing up to remove air bubbles before injection.*

FDA Label Image

Image (Insulin 16)

An instructional illustration showing a hand turning the dose selector on an Insulin Glargine Solostar injection pen, with an upward red arrow indicating the direction to adjust the dose. The dose window displays numerical values, demonstrating dose setting for subcutaneous injection.*

FDA Label Image

Image (Insulin 17)

An instructional illustration showing a hand holding an insulin pen at a horizontal angle with the needle pointing left, accompanied by a red arrow pointing left, indicating the direction for administration or removal.*

FDA Label Image

Image (Insulin 18)

An instructional illustration showing a hand holding an Insulin Glargine Solostar injection pen pressed against the skin for subcutaneous injection. The image includes a 10-second timer icon indicating the duration for which the injection pen should remain in place during administration, with a red arrow emphasizing the action of holding the pen steady.*

FDA Label Image

Label Image (Lbl500906178)

Insulin Glargine Solostar 100 units/mL injection solution label from A-S Medication Solutions. The label includes the product NDC 50090-6178-0, dosing information indicating five 3 mL prefilled pens per package, storage instructions to refrigerate between 36 to 46 degrees Fahrenheit and not to freeze, and the lot number 3459-0. The label also mentions that each mL contains 100 units of insulin glargine (3.6378 mg). The label includes a barcode and QR code for additional product information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.